Mirae Asset Global Investments’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-163,939
Closed -$6.68M 2477
2022
Q1
$6.68M Sell
163,939
-7,124
-4% -$298K 0.01% 782
2021
Q4
$7.64M Buy
171,063
+21,321
+14% +$1.03M 0.02% 762
2021
Q3
$7.47M Buy
149,742
+36,373
+32% +$1.89M 0.02% 731
2021
Q2
$6.08M Buy
113,369
+25,777
+29% +$1.29M 0.02% 772
2021
Q1
$4.02M Buy
87,592
+25,289
+41% +$1.21M 0.01% 780
2020
Q4
$3.04M Buy
62,303
+17,589
+39% +$840K 0.01% 787
2020
Q3
$1.98M Buy
44,714
+5,741
+15% +$242K 0.01% 781
2020
Q2
$1.5M Buy
+38,973
New +$1.58M 0.01% 779

Other funds holding ELAT

Mirae Asset Global Investments's ELAT Position: Q2 2022 in Review

Mirae Asset Global Investments sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q2 2022, closing a stake of 163,939 shares — an estimated $6.68M sold.

Mirae Asset Global Investments first reported a position in ELAT in Q2 2020 and held it in 8 quarters. The position peaked at $7.64M in Q4 2021. 35 funds tracked by Wall St. Rank hold ELAT as of Q2 2022.

  • Mirae Asset Global Investments reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q2 2022 after selling out during the quarter.
  • Mirae Asset Global Investments sold 163,939 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q2 2022, an estimated $6.68M.
  • Mirae Asset Global Investments first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q2 2020 and held it in 8 quarters.
  • Mirae Asset Global Investments's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $7.64M in Q4 2021.
  • 35 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q2 2022.

Based on Mirae Asset Global Investments's 13F filing for Q2 2022, filed 26 Jul 2022.